Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Clinical trial NCT03015909 · COMPLETED

Trial details

NCT number: NCT03015909
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Short Stature, Idiopathic Infant, Small for Gestational Age Growth Hormone Deficiency Chronic Renal Failure Turner Syndrome

Start date: 2016-08-11
Primary completion: 2017-12-21
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.